PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 24, 2026Vox Sanguinis0 citations

Integrated serological and molecular investigation of ABO subgroups underlying atypical ABO typing in southeastern Brazil

View Full Paper
CACarine Prisco ArnoniTVTatiane Aparecida Paula de VendrameNSNayara Morais Silva

Key Points

  • The aim is to identify prevalent ABO subgroups in Southeast Brazil and assess their impact on ABO typing accuracy.
  • Collected donor samples in São Paulo State, Brazil, and classified them into two groups.
  • Group 1 included samples with weak anti-A1 lectin reactivity; Group 2 included samples with atypical ABO typing.
  • Conducted serological tests and molecular characterization using PCR-RFLP and Sanger sequencing.
  • ABO*A2.01 allele was predominant in Group 1, representing 10.2% of type A donors.
  • Group 2 showed ABO*AW.09 as the most frequent allele at 33%, followed by ABO*AW.31 and ABO*AEL.01 at 11% each.
  • B subgroups were found in two samples linked to molecular changes, indicating their role in mistyping.

Abstract

Abstract Background and Objectives Numerous A and B subgroups can cause discrepancies between forward and reverse typing, weak reactivity or unexpected antibody patterns. This study aimed to identify the most prevalent ABO subgroups in a population of Southeast Brazil, characterize their serological profiles and evaluate their impact on ABO typing. Study Design and Methods Donor samples collected in São Paulo State, Brazil, were included in the study and classified into two groups according to predefined selection criteria. Group 1 comprised 27 samples with reduced or negative reactivity with anti‐A1 lectin, selected from 225 donors with routine Group A typing. Group 2 comprised 33 samples selected over a 2‐year period due to atypical ABO typing and subsequently subjected to complementary serological testing. All samples were molecularly characterized using polymerase chain reaction restriction fragment length polymorphism (PCR‐RFLP) and Sanger sequencing. Results In Group 1, the predominant allele was ABO*A2.01 , representing 10.2% of all type A donors. In Group 2, the most frequent variant allele was ABO*AW.09 (33%), followed by ABO*AW.31 (11%) and ABO*AEL.01 (11%). All these three subgroups were implicated in cases of ABO mistyping. B subgroups were identified in two samples and were associated with molecular changes in intron 1 (+5.8‐kb site). Conclusion Although ABO subgroups are uncommon, they occur in our population and directly affect blood typing. The results demonstrate the presence of clinically significant variants and highlight the need for vigilance in donor screening, including careful interpretation of typing results, the use of complementary serological testing and molecular analysis when necessary.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Arnoni et al. (2026) studied this question.

synapsesocial.com/papers/699d3ff8de8e28729cf64e0ahttps://doi.org/10.1111/vox.70223
Ask AI
Helpful
Bookmark
Share
View Full Paper